Ne Zha 2 has become the highest-grossing animation film of all time, earning more than Disney's Star Wars: The Force Awakens ...
CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...
Lexicon Pharmaceuticals Inc. said March 28 it will exclusively license its drug candidate LX9851 to Danish pharmaceutical ...
From misinformation as a silencing tool to Nobel-winning disasters, discover why questioning scientific consensus is both ...
Secretary of Defense Pete Hegseth plays the Washington suit game in his own way, but he's got another kind of unusual look — ...
HC Wainwright reiterated their buy rating on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research ...
The two posts of Hailey in a row also got fans chatting, since the "Baby" singer used to post family pics less frequently.
Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.
Retail investors lost hundreds of millions of dollars due to fraud perpetrated by Trevor Milton, the founder of once-hyped electric-truck maker Nikola Corp., prosecutors said in court documents just ...
The infamous Signal chat, reported by Jeffrey Goldberg, dehumanizes enemies and cheers for their destruction with emojis ...
The 22-year-old influencer will be the subject of an upcoming documentary from Emmy-winning production company Bungalow Media ...
Investor's Business Daily on MSN1d
Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1Novo Nordisk stock slipped 1.2% to 69.30. Novo Nordisk Is On A Licensing Spree. This is the second big weight-loss deal from Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback